Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

Nov 14, 2025 4:44 PM Eastern Standard Time Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. Share - Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 2026 - - Additional portfolio monetization efforts continue - - Company reports 3Q 2025 financial results - - $112.6 million in cash and cash equivalents and marketable securities as of September 30, 2025, as compared to ...